Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Jochen Reiser
Rush University Medical Center, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
Rush University Medical Center
Intellectual property rights (e.g., royalties, patents, copyrights) not from the awardee Institution
Dr. Reiser is a co-founder of Trisaq. he is the owner of approximately (b)(4) of stock. Trisaq holds several patent applications related to the understanding and treatment of proteinuric renal diseases. Dr. Reiser stands to gain royalties from present and future commercialization. Trisaq is not publicly traded.
A Humanized Mouse Model of FSGS
The goal of this grant proposal is to develop a novel humanized mouse model to study the pathogenesis of focal segmental glomerulosclerosis (FSGS). If our hypothesis is correct, we can induce bone marrow precursor cells in NSG mice after transfer of peripheral blood mononuclear cells (PBMCs) from patients with FSGS. Production of bone-marrow derived soluble urokinase plasminogen activator receptor (suPAR) will cause development of FSGS. This model will be a widely usable tool, which will allow for the studies of circulating factors in the pathogenesis of proteinuric kidney disease.
Filed on June 19, 2015.
Tell us what you know about Jochen Reiser's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Jochen Reiser filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Jochen Reiser | Rush University Medical Center | Conflict of Interest | Rush University Medical Center | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.